— Know what they know.
Not Investment Advice

7749.T JPX

Medikit Co.,Ltd.
1W: -1.1% 1M: -3.7% 3M: +0.1% YTD: -8.4% 1Y: +10.5% 3Y: +20.0% 5Y: +1.9%
¥2,772.00 ($17.56)
+5.00 (+0.18%)
 
Weekly Expected Move ±2.0%
¥2660 ¥2716 ¥2772 ¥2828 ¥2884
JPX · Healthcare · Medical - Instruments & Supplies · Tech Score Strong Sell · Power 34 · ¥40.1B mcap · 6M float · 0.039% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥40.1B ($254.3M)
52W Range2601-3095
Volume900
Avg Volume2,291
Beta0.10
Dividend¥100.00
Analyst Ratings
No analyst coverage
Company Info
CEOHiroaki Nakajima
Employees994
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2005-06-28
1-13-2, Yushima
Tokyo, TY 113-0034
JP
81 33 839 0492
About Medikit Co.,Ltd.

Established in Tokyo, Japan, in 1973, Medikit Co.,Ltd. specializes in the development, manufacturing, and global distribution of advanced medical devices for vascular access. Their comprehensive product portfolio encompasses various intravenous (IV) catheters, such as Supercath 5, Supercath Z3V, and Supercath Ztu-V. They further provide solutions for hemodialysis, including Supercath PRO, Supercath NEO, and Supercath Clampcath, alongside interventional products like Supersheath and Mongoose. These critical medical instruments find application in diverse healthcare settings, notably in anesthesiology departments, operating theaters, intensive care units (ICUs), and within both dialysis and cardiology facilities. Medikit Co.,Ltd. expands its market reach by leveraging a network of distributors, serving approximately 20 countries and territories throughout the European Union and the Americas.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms